Spotlight: Agouron Makes Pact for AIDS Drug
- Share via
La Jolla-based Agouron Pharmaceuticals Inc. said it could pay Immune Response Corp. of Carlsbad as much as $77 million over the next two years as part of a development and marketing pact for IR’s AIDS drug, Remune. The drug is in late-stage testing and might face Food and Drug Administration scrutiny next year. Agouron makes the AIDS drug Viracept and intends to add another product through the deal. “It should put Immune Response on the map,” said Prudential Securities analyst Caroline Copithorne.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
